The objective of this paper is to identify predictors for the response to treatment of acute lupus hemophagocytic syndrome (ALHS).
Methods
We reviewed seven cases with ALHS admitted to our hospital and published ALHS cases identified in the 2001–2014 Medline database, and then conducted univariate and multivariate analyses to identify predictors for the response to treatment.
Results
Review of our cases showed a significant and negative correlation between serum ferritin and anti-DNA antibody (p = 0.0025). All three patients treated with cyclosporine A (CsA) were considered responders despite high serum ferritin and corticosteroid resistance. We also reviewed 93 patients with ALHS identified in 46 articles. Multiple logistic regression analysis identified C-reactive protein (CRP) (OR 0.83, p = 0.042) and hemoglobin (OR 1.53, p = 0.026) measured at diagnosis of ALHS as significant predictors of the response to corticosteroid monotherapy. Moreover, among 32 patients treated with CsA, serum ferritin was significantly higher in CsA responders (12163 ± 16864 µg/l, n = 22) than in non-responders (3456 ± 6267/µg/l, p = 0.020, n = 10). Leukocyte count was significantly lower in the CsA responders (1940.0 ± 972.3/µl) than in the non-responders (3253 ± 2198/µl, p = 0.034).
Conclusion
Low CRP and high hemoglobin can predict a positive response to corticosteroid monotherapy while high serum ferritin and low leukocyte count can predict a positive response to CsA in patients with ALHS and therefore, when corticosteroid monotherapy is not effective in such cases, CsA could be the first choice of an additional immunosuppressive agent.
LarrocheC. Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment. Joint Bone Spine2012; 79: 356–361.
2.
KumakuraSIshikuraHKondoMMurakawaYMasudaJKobayashiS. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol2004; 14: 205–215.
3.
FukayaSYasudaSHashimotoT. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: Analysis of 30 cases. Rheumatology (Oxford)2008; 47: 1686–1691.
4.
WongKFHuiPKChanJKCChanYWHaSY. The acute lupus hemophagocytic syndrome. Ann Intern Med1991; 114: 387–390.
5.
LambotteOKhellafMHarmoucheH. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore)2006; 85: 169–182.
6.
KimJMKwokSKJuJHKimHYParkSH. Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: A case-control study and literature review. J Rheumatol2012; 39: 86–93.
7.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
8.
ImashukuS. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol1997; 66: 135–151.
9.
HenterJIHorneAAricóM. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer2007; 48: 124–131.
MoriYSugiyamaTChibaR. A case of systemic lupus erythematosus with hemophagocytic syndrome and cytophagic histiocytic panniculitis [article in Japanese]. Ryumachi2001; 41: 31–36.
12.
MoriguchiNSatoWMiyataHYoshiokaK. Systemic lupus erythematosus with bilateral salivary gland swelling and clouding of consciousness accompanied by hemophagocytic syndrome—a study of serial determination of serum cytokines [article in Japanese]. Rinsho Ketsueki2002; 43: 931–936.
13.
InamoYRyouNAbeO. A case report: A pediatric patient with acute lupus hemophagocytic syndrome; differences from reactive hemophagocytosis caused by hypercytokinemia. Mod Rheumatol2002; 12: 72–75.
14.
FunauchiMOhnoMYamagataTNozakiYKinoshitaKKanamaruA. Effects of liposteroid on the hemophagocytic syndrome in systemic lupus erythematosus. Lupus2003; 12: 483–485.
15.
HoshiKMatsudaMIshikawaM. Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus. Clin Rheumatol2004; 23: 252–255.
16.
MootsikapunPSirijerachaiCChansungKNanagaraR. Acute lupus hemophagocytic syndrome: Report of a case and review of the literature. J Med Assoc Thai2004; 87: 333–339.
17.
KanekoKMatsudaMSekijimaY. Acute respiratory distress syndrome due to systemic lupus erythematosus with hemophagocytic syndrome: An autopsy report. Clin Rheumatol2005; 24: 158–161.
18.
YamadaTHandaYKamikawaTMachinoHSuzukiKMiyataK. A case of systemic lupus erythematosus associated with thrombotic thrombocytopenic purpura and hemophagocytic syndrome [article in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi2006; 29: 384–388.
HagiwaraKSawanoboriMNakagawaYSatoTAkiyamaOTakemuraT. Reactive hemophagocytic syndrome in a case of systemic lupus erythematosus that was diagnosed by detection of hemophagocytosing macrophages in peripheral blood smears. Mod Rheumatol2006; 16: 169–171.
21.
HenzanTNagafujiKTsukamotoH. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol2006; 81: 59–61.
22.
AvcinTTseSMSchneiderRNganBSilvermanED. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr2006; 148: 683–686.
23.
McCannLJHassonNPilkingtonCA. Macrophage activation syndrome as an early presentation of lupus. J Rheumatol2006; 33: 438–440.
24.
IdeguchiHOhnoSTakaseK. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology (Oxford)2007; 46: 1621–1622.
25.
PérardLCostedoat-ChalumeauNLimalN. Hemophagocytic syndrome in a pregnant patient with systemic lupus erythematosus, complicated with preeclampsia and cerebral hemorrhage. Ann Hematol2007; 86: 541–544.
26.
QianJYangCD. Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: Two case reports and literature review. Clin Rheumatol2007; 26: 807–810.
27.
TakahashiNNaniwaTBannoS. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol2008; 18: 72–75.
28.
YeapSTSheenJMKuoHCHwangKPYangKDYuHR. Macrophage activation syndrome as initial presentation of systemic lupus erythematosus. Pediatr Neonatol2008; 49: 39–42.
29.
RajamLPrasadVYatheeshaBL. Reactive hemophagocytic syndrome. Indian J Pediatr2008; 75: 1261–1263.
30.
KampitakT. Fatal Kikuchi-Fujimoto disease associated with SLE and hemophagocytic syndrome: A case report. Clin Rheumatol2008; 27: 1073–1075.
31.
TakizawaYMaruyamaJSetoguchiK. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin. Scand J Rheumatol2009; 38: 492–494.
32.
TabataRTabataCTeradaMNagaiT. Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases. Clin Rheumatol2009; 28: 461–464.
33.
YoshidaSTakeuchiTItamiY. Hemophagocytic syndrome as primary manifestation in a patient with systemic lupus erythematosus after parturition [article in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi2009; 32: 66–70.
34.
ZulianFPiccininiPMartiniGJoriniMde BenedictisFM. Macrophage activation syndrome as trigger event for systemic lupus erythematosus in children. J Paediatr Child Health2009; 45: 621–622.
35.
BotelhoCFerrerFFranciscoLMaiaPMendesTCarreiraA. Acute lupus hemophagocytic syndrome: Report of a case. Nefrologia2010; 30: 247–251.
36.
CarvalheirasGAnjoDMendonçaTVasconcelosCFarinhaF. Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus—case report and literature review. Lupus2010; 19: 756–761.
37.
KamiyaKKurasawaKAraiS. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol2010; 20: 81–85.
38.
TakiHShinodaKHounokiH. Presenting manifestations of hemophagocytic syndrome in a male patient with systemic lupus erythematosus. Rheumatol Int2010; 30: 387–388.
39.
CamposLMOmoriCHLotitoAPJesusAAPortaGSilvaCA. Acute pancreatitis in juvenile systemic lupus erythematosus: A manifestation of macrophage activation syndrome?Lupus2010; 19: 1654–1658.
40.
YamamuraKOhgaSNishiyamaK. Recurrent atrial fibrillation after high-dose methylprednisolone therapy in a girl with lupus-associated hemophagocytic syndrome. Lupus2011; 20: 871–875.
41.
ArnezMAde AzevedoMNBicaBE. Reactive haemophagocytic syndrome in a systemic lupus erythematosus patient: Case report [article in English, Portuguese]. Rev Bras Rheumatol2012; 52: 790–795.
42.
KeithMPPitchfordCBernsteinWB. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus. J Clin Rheumatol2012; 18: 134–137.
43.
KikuchiHYamamotoTAsakoKTakayamaMShirasakiROnoY. Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus. Mod Rheumatol2012; 22: 308–311.
44.
WatanabeHHiraseNGodaHNishikawaHIkuyamaS. Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus. Mod Rheumatol2012; 22: 284–289.
45.
LinCIYuHHLeeJH. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol2012; 31: 1223–1230.
46.
UedaYYamashitaHTakahashiYKanekoHKanoTMimoriA. Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: Three case reports and literature review. Clin Rheumatol2014; 33: 281–286.
47.
JungSY. Hemophagocytic syndrome diagnosed by liver biopsy in a female patient with systemic lupus erythematosus. J Clin Rheumatol2013; 19: 449–451.
48.
KimJMKwokSKJuJH. Macrophage activation syndrome resistant to medical therapy in a patient with systemic lupus erythematosus and its remission with splenectomy. Rheumatol Int2013; 33: 767–771.
49.
BakshiJHassanSD’CruzDChanA. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus. Lupus2013; 22: 1544–1546.
50.
HasegawaHMizoguchiFKohsakaHMiyasakaN. Systemic lupus erythematosus with cytophagic histiocytic panniculitis successfully treated with high-dose glucocorticoids and cyclosporine A. Lupus2013; 22: 316–319.
SoMWKooBSKimYJKimYGLeeCKYooB. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus. Mod Rheumatol2014; 24: 855–857.
53.
MehtaBEfthimiouP. Ferritin in adult-onset Still’s disease: Just a useful innocent bystander?Int J Inflam2012; 2012: 298405–298405.
54.
VillanuevaJLeeSGianniniEH. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther2005; 7: R30–R37.
55.
KounamiSYoshiyamaMNakayamaK. Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis. Acta Haematol2005; 113: 124–129.
56.
RosárioCZandman-GoddardGMeyron-HoltzEGD’CruzDPShoenfeldY. The hyperferritinemic syndrome: Macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med2013; 11: 185–185.
